Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts

Curr Opin Investig Drugs. 2001 Oct;2(10):1366-7.

Authors

T J Walsh¹, A H Groll

Affiliation

¹ Immunocompromised Host Section, National Cancer Institute, Bethesda, MD 20892, USA. walsht@mail.nih.gov

PMID: 11890348

No abstract available

Publication types

Review

MeSH terms

Animals
Aspergillosis / drug therapy*
Aspergillosis / microbiology
Aspergillus / drug effects*
Humans
Immunologic Deficiency Syndromes / drug therapy*
Immunologic Deficiency Syndromes / microbiology